Bio-Techne Acquires CyVek for $95,000,000

  • Feed Type
  • Date
  • Company Name
  • Mailing Address
    2 Barnes Industrial Road South Wallingford, CT 06492 USA
  • Company Description
    The objective of the CyVek technology is to provide a robust platform for multiplexed proteomics, particularly to serve the market needs of biomarker validation.
  • Website
  • Transaction Type
  • Transaction Amount
  • Transaction Round
  • Proceeds Purposes
  • M&A Terms
    Bio-Techne Corporation (NASDAQ: TECH) announced today that it has agreed to acquire CyVek, Inc. (CyVek) for $60 million in cash, plus a potential earn-out payment of up to $35 million based on CyVek revenue over the 30-month period following the closing and an additional potential earn-out payment based on CyVek revenue through 2020 in excess of $100 million.

Trending on Xconomy